{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:14Z","timestamp":1753891874211,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hepatoblastoma (HB) is the most common pediatric hepatic malignancy. Despite the progress in HB treatment, investigating HB pathomechanisms to optimize stratification and therapies remains a focal point to improve the outcome for high-risk patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we pointed to explore the impact of these mechanisms in HB. An observational study was performed on liver samples from a cohort of 17 patients with a diagnosis of HB and two normal liver samples. The <jats:italic>in vitro<\/jats:italic> experiments were executed on the Huh6 human HB cell line treated with the FAK inhibitor TAE226.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results highlight a significant up-regulation of mRNA and protein expression of FAK in livers from HB with respect to normal livers. The increased protein expression of total and Tyr397 phosphorylated FAK (pTyr397FAK) was significantly correlated with the expression of some epigenetic regulators of histone H3 methylation and acetylation. Of note, the expression of pTyr397FAK, N-methyltransferase enzyme (EZH2) and tri-methylation of the H3K27 residue correlated with tumor size and alpha-fetoprotein (AFP) levels. Finally, TAE226 caused a significant reduction of pTyr397FAK, epigenetic regulators, <jats:italic>AFP<\/jats:italic>, <jats:italic>EPCAM<\/jats:italic>, <jats:italic>OCT4<\/jats:italic>, and <jats:italic>SOX2<\/jats:italic>, in association with anti-proliferative and pro-apoptotic effects on HB cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggest a role of FAK in HB that requires further investigations mainly focused on the exploration of its effective diagnostic and therapeutic translatability.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1397647","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T05:06:53Z","timestamp":1718341613000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Focal adhesion kinase and its epigenetic interactors as diagnostic and therapeutic hints for pediatric hepatoblastoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Maria Rita","family":"Braghini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"De Stefanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Tiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolo\u2019","family":"Cicolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pezzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Tocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Spada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Alaggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Alisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Francalanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1093526619875228","article-title":"Hepatoblastoma and pediatric hepatocellular carcinoma: an update","volume":"23","author":"Ranganathan","year":"2020","journal-title":"Pediatr Dev Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1049727","article-title":"A population-based assessment of metastatic hepatoblastoma in Texas reveals ethnic disparities","volume":"11","author":"Espinoza","year":"2023","journal-title":"Front Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020467","article-title":"Outcomes of patients treated for hepatoblastoma with low alpha-fetoprotein and\/or small cell undifferentiated histology: A report from the children\u2019s hepatic tumors international collaboration (CHIC)","volume":"15","author":"Trobaugh-Lotrario","year":"2023","journal-title":"Cancers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40880\u2013019-0411\u20137","article-title":"Incidence trends and survival prediction of hepatoblastoma in children: a population-based study","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20132045(16)30598\u20138","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00803","article-title":"Small cell undifferentiated histology does not adversely affect outcome in hepatoblastoma: A report from the children\u2019s oncology group (COG) AHEP0731 study committee","volume":"40","author":"Trobaugh-Lotrario","year":"2022","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2011.09.003","article-title":"Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability","volume":"46","author":"Ueda","year":"2011","journal-title":"J Pediatr Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.21037\/tgh.2019.12.03","article-title":"Hepatoblastoma: current knowledge and promises from preclinical studies","volume":"5","author":"Calvisi","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.025","article-title":"Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications","volume":"73","author":"Carrillo-Reixach","year":"2020","journal-title":"J Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.009","article-title":"Epitranscriptomics in liver disease: Basic concepts and therapeutic potential","volume":"73","author":"Zhao","year":"2020","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110851","article-title":"WNT\/\u03b2-catenin signaling in the development of liver cancers","volume":"132","author":"He","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00383\u2013017-4115\u20132","article-title":"Utility of PAS and \u03b2-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas","volume":"33","author":"Bera","year":"2017","journal-title":"Pediatr Surg Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.04.035","article-title":"Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults","volume":"77","author":"Sumazin","year":"2022","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165795","article-title":"Focal adhesion kinase (FAK) over-expression and prognostic implication in pediatric hepatocellular carcinoma","volume":"21","author":"Francalanci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23041998","article-title":"New insights on the nuclear functions and targeting of FAK in cancer","volume":"23","author":"Pomella","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/gr.154492.113","article-title":"Whole-genome se-quencing identifies recurrent mutations in hepatocellular carcinoma","volume":"23","author":"Kan","year":"2013","journal-title":"Genome Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18010099","article-title":"Focal adhesion kinase: insight into molecular roles and functions in hepatocellular carcinoma","volume":"18","author":"Panera","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/cdd.2017.34","article-title":"Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2","volume":"24","author":"Gnani","year":"2017","journal-title":"Cell Death Differ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s13046\u2013021-02154\u20138","article-title":"Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects","volume":"40","author":"Romito","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1593\/tlo.12505","article-title":"FAK inhibition decreases hepatoblastoma survival both in vitro and in vivo","volume":"6","author":"Gillory","year":"2013","journal-title":"Transl Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0002\u20139440(10)64567\u20131","article-title":"Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome","volume":"157","author":"Weber","year":"2000","journal-title":"Am J Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.741526","article-title":"Copy number alterations in hepatoblastoma: literature review and a Brazilian cohort analysis highlight new biological pathways","volume":"11","author":"Barros","year":"2021","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003800","article-title":"Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation","volume":"3","author":"Lietha","year":"2008","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13046\u2013022-02297\u20132","article-title":"Epigenetic remodelling in human hepatocellular carcinoma","volume":"41","author":"Braghini","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228857","article-title":"The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228452","article-title":"A lipidomic signature complements stemness features acquisition in liver cancer cells","volume":"21","author":"Rivas Serna","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.02.040","article-title":"PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt\/\u03b2-catenin signaling","volume":"450","author":"Fan","year":"2019","journal-title":"Cancer Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313135","article-title":"The curious case of the hepG2 cell line: 40 years of expertise","volume":"22","author":"Arzumanian","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.7733","article-title":"Prognostic significance of c-Met, \u03b2-catenin and FAK in patients with hepatocellular carcinoma following surgery","volume":"15","author":"Gong","year":"2018","journal-title":"Oncol Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27402","article-title":"FAK is required for c-Met\/\u03b2-catenin-driven hepatocarcinogenesis","volume":"61","author":"Shang","year":"2015","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30707","article-title":"Focal adhesion kinase and \u03b2-catenin cooperate to induce hepatocellular carcinoma","volume":"70","author":"Shang","year":"2019","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27797","article-title":"H19 suppresses the growth of hepatoblastoma cells by promoting their apoptosis via the signaling pathways of miR-675\/FADD and miR-138\/PTK2","volume":"120","author":"Ge","year":"2019","journal-title":"J Cell Biochem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1038\/s41467\u2013021-25430\u20139","article-title":"Genetic and epigenetic basis of hepatoblastoma diversity","volume":"12","author":"Nagae","year":"2021","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jhep.2023.05.031","article-title":"Identification and experimental validation of druggable epigenetic targets in hepatoblastoma","volume":"79","author":"Claver\u00eda-Cabello","year":"2023","journal-title":"J Hepatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13046\u2013019-1265\u20131","article-title":"The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review","volume":"38","author":"Zhou","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s12276\u2013020-0447\u20134","article-title":"Targeting focal adhesion kinase in cancer cells and the tumor microenvironment","volume":"52","author":"Murphy","year":"2020","journal-title":"Exp Mol Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13104\u2013019-4389\u20137","article-title":"Pharmacological profiling of a dual FAK\/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models","volume":"12","author":"Fukami","year":"2019","journal-title":"BMC Res Notes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3512","article-title":"Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells","volume":"41","author":"Yu","year":"2018","journal-title":"Int J Mol Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7555\/JBR.37.20230067","article-title":"Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity","volume":"37","author":"Xu","year":"2023","journal-title":"J BioMed Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1186\/s12885\u2013021-08893\u20133","article-title":"Development and validation of genomic and epigenomic signatures associated with tumor immune microenvironment in hepatoblastoma","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101684","article-title":"DNA methylation as a key epigenetic player for hepatoblastoma characterization","volume":"45","author":"Rivas","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41419-022-04848-z","article-title":"Mechanism of cancer stemness maintenance in human liver cancer","volume":"13","author":"Liang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022\u2013057424","article-title":"Prognosis of children undergoing liver transplantation: A 30-year European study","volume":"150","author":"Baumann","year":"2022","journal-title":"Pediatrics"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1397647\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T05:06:57Z","timestamp":1718341617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1397647\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":43,"alternative-id":["10.3389\/fonc.2024.1397647"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1397647","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"article-number":"1397647"}}